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ABSTRACT 
Introduction: The purpose was to systematically re- 
view the literature regarding interventions to im- 
prove daily activity in individuals with chronic ob- 
structive pulmonary disease (COPD) and chronic 
heart failure (CHF). Methods: Articles found by 
searching CINAHL Plus Full-Text, PubMed, and 
PsycINFO databases were included in the review if 
the study examined the effect of exercise- and/or psy- 
chosocial-based interventions on daily activity in in- 
dividuals with COPD or CHF. Article selection, data 
extraction, and evaluation of methodological rigor 
and quality were performed by two independent re- 
viewers. Nine articles for COPD and seven articles for 
CHF met the inclusion criteria and were used in this 
review. Results: Only four of nine studies in COPD 
and two of seven studies in CHF resulted in improve- 
ment in daily activity, and of those, all but one study 
included a psychosocial-based intervention. Improve- 
ments in daily activity did not occur concurrently 
with changes in other outcomes such as exercise per- 
formance, quality of life, functional status, or anxi- 
ety/depression in COPD or CHF. Conclusions: Exer- 
cise-based interventions serve a limited, if any, role in 
improving daily activity in individuals with COPD 
and CHF. Disrupting the cycle of inactivity and de- 
conditioning requires more than just addressing the 
deconditioning aspect of this cycle. Psychosocial-bas- 
ed interventions are a promising, but under-investi- 
gated, intervention. 
 
Keywords: Heart Failure; Chronic Obstructive 
Pulmonary Disease; Daily Activity 
1. INTRODUCTION 
Daily activity is associated with a variety of health out-
comes in patients with chronic obstructive pulmonary 
disease (COPD) and chronic heart failure (CHF), in- 
cluding life expectancy and mortality [1-7]. However, 
rehabilitative interventions for improving daily activity 
have not been well-studied. Very low levels of physical 
activity measured by activity questionnaires are associ- 
ated with hospitalization due to exacerbation [2,3] and 
mortality in patients with COPD [2]. Objective meas- 
urement of daily activity with accelerometry in patients 
with COPD reaffirmed this finding; daily activity was an 
independent prognostic factor for mortality and hospi- 
talization [4]. Similarly, in patients with CHF, low daily 
activity as measured by accelerometry is associated with 
lower survival and mortality [5-7]. It is therefore impor- 
tant to understand which interventions are effective for 
improving daily activity. 
Although COPD and CHF have very distinct patho- 
physiologic mechanisms, both result in exercise intoler- 
ance and similar physically-limiting symptoms such as 
breathlessness and fatigue that lead to activity avoidance 
and a subsequent cycle of inactivity and deconditioning 
[8-12]. 
Chronic obstructive pulmonary disease is character- 
ized by progressive airflow obstruction caused by a loss 
of elastic recoil and airway narrowing that is not fully 
reversible in response to bronchodilators [13]. Many 
individuals with COPD are inactive in daily life, most 
likely as a strategy to minimize dyspnea [14]. The me- 
chanisms for dyspnea and exercise intolerance are multi- 
factorial and include increased resistance to airflow (es- 
pecially during expiration) [15], impaired gas exchange 
resulting in hypoxemia and hypercapnia [15], dynamic 
hyperinflation [16], inspiratory muscle weakness, and 
skeletal muscle dysfunction [17]. 
Chronic heart failure is a syndrome of cardiac dys- 
function characterized by insufficient cardiac output [15], 
resulting in limited exercise performance, abnormal ven- 
tilatory response, impaired ventilatory muscle strength, 
and low perfusion of skeletal muscles with subsequent *Corresponding author. 
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skeletal muscle dysfunction [8]. The symptoms that re- 
sult from these various mechanisms of exercise intoler- 
ance lead to activity restriction and further functional 
deterioration [9]. 
Although the exertional symptoms associated with 
limited exercise tolerance may appear to account for in- 
activity in individuals with COPD and CHF, psychoso- 
cial factors such as depression and self-efficacy have also 
been demonstrated to be significant determinants of par- 
ticipation in daily activities [18,19]. On average, indi- 
viduals with chronic diseases are 1.5 - 2.0 times more 
likely to be depressed [20]. Prevalence of major depress- 
sion in individuals with COPD and CHF have been re- 
ported to be as high as 42% and 20%, respectively 
[21,22]. Although decreased activity is most pronounced 
in older patients with significant depression, individuals 
with less severe depression are also at risk for decline in 
daily activity [23]. The Longitudinal Aging Study Am- 
sterdam found that respondents with emerging depress- 
sion were more likely to transition to a sedentary lifestyle 
[24]. 
Self-efficacy, defined as an individual’s beliefs about 
his or her ability to exercise control over events that af- 
fect his or her life [25], is another potentially significant 
determinant of daily activity. Oka et al. [26] found that 
self-efficacy is a stronger predictor of daily physical ac- 
tivity in individuals with CHF than physical fitness 
measures or RPE. In individuals with COPD, Arnold et 
al. [27] found greater self-efficacy in those reporting 
better physical functioning. Specifically with regard to 
walking, lower walking self-efficacy as measured by the 
Self-Efficacy Questionnaire-Walking is associated with a 
decrease in physical activity in individuals with CHF 
[28], and self-efficacy is associated with objective phy- 
sical performance measures such as the six-minute walk 
test (6MWT) in individuals with COPD [29]. 
Rehabilitative interventions for improving daily activ- 
ity have not been well-studied. Ng et al. [30] systematic- 
cally reviewed the effect of exercise training on daily 
activity in individuals with COPD. They found a small 
effect of exercise training on daily activity based on two 
randomized trials and five cohort studies. Unfortunately, 
their review only examined exercise interventions and 
did not account for other confounding determinants of 
daily activity. No prior systematic reviews have been 
conducted to examine interventions for improving daily 
activity of individuals with CHF, but three studies have 
failed to demonstrate improvement in daily activity de- 
spite improvements in exercise tolerance following exer- 
cise training [31-33]. Given that exercise-based inter- 
venetions may not result in substantial changes in daily 
activity, other interventions that address impairments in 
psychosocial domains may be more appropriate for im- 
proving daily activity [34]. No prior systematic review 
has addressed non-exercise based interventions for low 
daily activity in individuals with COPD or CHF. 
In summary, COPD and CHF result in a cycle of inac- 
tivity and deconditioning due to the symptoms of fatigue 
and breathlessness associated with exercise intolerance. 
As daily activity decreases, the risk of adverse health 
outcomes increases. Furthermore, psychosocial factors 
may substantially confound this cycle of inactivity and 
deconditioning such that interventions for improving 
daily activity may need to account for these additional 
factors, especially given that exercise-based intervene- 
tions may have a minimal effect. Therefore, the purpose 
of the present systematic review is to consider and ex- 
amine a broader range of interventions that are used to 
improve daily activity in individuals with COPD and 
CHF. 
2. METHODS 
2.1. Literature Search 
The literature search was conducted by searching within 
the article text using CINAHL Plus Full-Text (Ebsco), 
PubMed, and PscyINFO databases on July 31, 2012. The 
topics of “heart failure” and “COPD” were each searched 
individually in conjunction with the following keywords: 
“daily activity”, “daily activities”, “physical activity”, 
“physical activities”, and “energy expenditure”. 
2.2. Study Selection Criteria 
Studies were included if physical- or psychosocial-based 
interventions were used and if a change in daily activity 
was assessed after the intervention period had concluded. 
Only peer-reviewed studies were included in the review 
and no limitations were imposed regarding year of pub- 
lication. Studies were excluded if no full text was avail- 
able or if the article was not published in the English 
language. To limit selection bias, two authors (BK and 
BS) independently searched databases and individually 
selected studies based on inclusion and exclusion criteria. 
Differences in study selection were discussed with a third 
author and fourth author (MS and PS), and a consensus 
was reached by the authors if opinions varied. 
2.3. Level of Evidence 
Strength of evidence for each study was appraised using 
levels of evidence as described by Strauss et al. [35]. The 
levels of evidence are ranked 1 to 5, with 1 being the 
highest level of evidence. Each study was independently 
assessed by the authors (BK and BS). If level of evidence 
ratings varied by author, differences were discussed with 
a third author and fourth author (MS and PS) and a con- 
sensus was reached. Articles rated 1b (randomized trial), 
2b (cohort study), 3b (individual case control study) and 
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3.1.2. Levels of Evidence 4 (low quality case control study) were included in this 
review. All seven studies [37-43] were Level 1b based on being 
randomized in design and having a methodological rigor 
score greater than or equal to 60%. 2.4. Methodological Rigor 
The methodological quality of studies included was as- 
sessed using the Medlicott and Harris [36] scale for 
methodological rigor. Methodological rigor was rated as 
follows: “Strong” 71% to 100%, “Moderate” 60% to 
70%, and “Weak” 59% or less. Percentages were calcu- 
lated by dividing the amount of criterion “met” by the 
total amount of criterion possible that could be “met” for 
that particular article. Randomized controlled trials with 
“weak” methodological rigor were given a level of evi- 
dence designation “2b.” Methodological rigor was inde- 
pendently assessed by the authors (BK and BS). Differ- 
ences in study selection were discussed with a third au- 
thor and fourth author (MS and PS) and a consensus was 
reached by the authors if opinions varied. 
3.1.3. Methodological Rigor 
Methodological rigor scores ranged from 70% to 90% 
and are summarized in Table 1. Five articles [38,40-43] 
were rated as “strong” (“yes” percentage from 75 - 100), 
two [37,39] were judged to be “moderate” (“yes” per- 
centage from 50 - 74), and none were determined to be 
“weak” (“yes” percentage from 0 - 49). The most notable 
deficiencies in rigor were related to randomization, 
blinding, and long term follow-up. 
 
 
3. RESULTS 
3.1. Heart Failure 
3.1.1. Literature Search 
Three hundred and sixteen unique articles were found 
using the search strategy previously outlined. The most 
frequent reasons for exclusion were heterogeneous 
populations, no measure of daily activity, or a lack of a 
physical or psychosocial intervention. Ultimately, seven 
studies [37-43] met the inclusion criteria for this review. 
The results of the search strategy are outlined in Figure 
1. Included studies were then analyzed for their methods, 
outcome measures, level of evidence, and methodologi- 
cal rigor. Tables 1 and 2 summarize the methodological 
rigor and extracted data of the included studies. Figure 1. Search results for chronic heart failure. 
 
Table 1. Methodological rigor of included studies in individuals with chronic heart failure. 
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Gottlieb et al. 1990 Y Y Y Y Y Y N Y N Y 80% 1b 
Willenheimer et al. 2001 Y Y Y Y N N Y Y Y Y 80% 1b 
Van den Berg-Emons et al. 2004 Y Y Y Y Y Y Y N N Y 80% 1b 
Brodie et al. 2005 Y Y Y Y Y Y N Y N N 70% 1b 
Witham et al. 2005 Y Y Y Y Y Y Y Y N Y 90% 1b 
Mueller et al. 2007 Y N Y Y Y Y N Y Y N 70% 2b 
Witham et al. 2012 Y Y Y Y Y Y Y Y N Y 90% 1b 
Y = yes; N = no. 
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Table 2. Extracted data for studies in individuals with chronic heart failure. 
OUTCOMES Study, Level  
of Evidence,  
and Rigor 
Subjects 
 
Interventions 
 Measure of Daily activity Other 
Gottlieb et al. 
 
1999 
 
RCT 
 
Level 1b 
 
M&HR 80% 
Treatment: 
N:11 
M/F: 11/0 
Ages: 67(7) 
LVEF(%): 22(8) 
NYHC: 
II: 5 
III:6 
 
Control: 
N:14 
M/F: 11/3 
Ages: 64(10) 
LVEF(%): 25(10) NYHC: 
II: 4 
III: 10 
 
Crossover: 
N:5 
No characteristics  
reported for 
cross-over group 
Visits 
3x/week for 6 months 
 
Intensity 
Increased per patient  
tolerance using Borg  
Scale 12 to 13 
 
Type: 
UE/LE ergometer and  
treadmill walking.  
Progressed to 15 min on  
bike and 30 min on  
treadmill 
 
Control Group  
Usual care unspecified 
 
Hip accelerometer (kcal/d) 
Treatment + Crossover 
No  286(149)361(224) 
 
Control 
No  reported 
 
Doubly labeled water (kcal/d) 
Treatment + Crossover 
No  386(357) 273(133) 
 
Control 
No  reported 
 
 
 
 
Exercise Performance: 
6MWT (m) 
Treatment 
395(49)  by 50(59)*ǂ 
Control 
No  410(39)  by 19(41) 
 
Peak VO2 (mL/kg/min) 
Treatment + Crossover 
 15(3)17(3)*ǂ 
Control 
No  
 
Functional Status: 
Functional Status Assessment, 
SF-36 
No  in either group 
 
Quality of Life:  
MLHFQ 
No  in either group 
 
Anxiety/Depression: 
CES-D 
No  in either group 
Willenheimer  
et al.  
 
2001 
 
RCT 
 
Level 1b 
 
M&HR 80% 
Treatment 
N:17 
Age: 64(5) 
M/F: 12/5 
LVEF: 35(12) 
NYHC: 2.1(.7) 
 
Control 
N:20 
Age: 64(8) 
M/F: 14/6 
LVEF: 38(10) 
NYHC: 2.4(0.7) 
 
 
Visits 
15 minutes, 2x/wk for  
first 6 weeks, followed 
by 45 minutes sessions  
3x/wk for 11 weeks  
(total of 17 weeks),  
follow-up at 10 months 
 
Intensity 
HR corresponding to  
80% VO2 max  
 
Type:  
Cycle ergometer  
interval training for 90  
seconds followed by 30  
second rest 
 
Control Group  
Unspecified 
Habitual Physical Activity  
Journal (units) 
Training Group: 
No  70(97)60(85)48(41) 
 
Control Group: 
No  71(68)42(55)32(41) 
 
Exercise Performance: 
Peak VO2 (mL/kg/min) 
Treatment 
No  16.2(3.2)17.3(4.4) 
Control 
No  16.1(3.3)16.6(3.6) 
 
Quality of Life:  
Patient Global Assessment of  
Change in Quality of Life 
Training Group: 
 0(0)1.3(1.3)0.7(0.9)*ǂ 
Control Group: 
No  0(0)0.4(1.4)0.0(1.0) 
 
Van den  
Berg-Emons  
et al.  
 
2004 
 
RCT 
 
Level 1b 
 
M&HR 80% 
Treatment  
N:18 
Age: 58.6(12.1) 
M/F: 12/6 
LVEF(%):24(9) 
NYHC:  
II: 10 
III: 8 
 
Control 
N:16 
Age: 58.6 (10.6) 
M/F: 13/3 
LVEF(%): 27.6(6.0) 
NYHA class 
II: 10 
III: 6 
 
Visits 
1 hour, 2x/wk for 3 mos 
 
Intensity 
Target HR 60% of HR  
Reserve 
 
Type 
Cycle ergometer, walking, 
and games in addition  
to standard care 
 
Control Group 
Standard medical care 
 
Four uni-axial accelerometers 
No statistically significant changes 
were noted when comparing:  
duration of dynamic activities,  
body motility, motility during  
walking, # of transitions, walking 
periods >10s, walking periods >5s 
 
Exercise Performance:  
6MWT (m) 
Treatment 
↑ 455(71)501(96)* 
Control 
↑ 435(77)448(84)* 
 
Peak VO2 (mL/kg/min) 
Treatment 
↑ 16.6(4.2)17.8(4.0)* 
Control 
No  16.1(3.8)15.8(2.9) 
 
Extensor Peak Torque (Nm/kg) 
Treatment 
↑ 0.78(0.29)0.88(0.32)* 
Control 
No  0.74(0.20)0.73(0.21) 
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Continued 
Brodie et al. 
 
2005 
 
RCT 
 
Level 1b 
 
M&HR 70% 
Treatment Alone 
N:22 
M/F: NR 
Ages: 78(6.1) 
LVEF(%): 31.0(8.5)
NYHC: NR 
 
Standard Care 
N:18 
M/F: NR 
Ages: 76(6.4)  
LVEF(%): 27.7(5.8)
NYHC: NR 
 
Combined  
Treatment/Standard
Care 
N:20 
M/F: NR 
Ages: 79(6.9)  
LVEF(%): 31.3(5.9)
NYHC: NR 
Visits 
8, 1-hr sessions over 5  
months 
 
Type 
Treatment: Motivational 
interviewing technique 
to decrease ambivalence 
to physical activity 
 
Standard Care: Advised 
in structured exercise  
program including  
information on local  
options/opportunities. 
 
Leisure-time physical activity  
questionnaire and a 3-day  
physical activity diary 
Treatment Alone 
Energy Expenditure  
(kcal/kg/day):  
↑ 6.6(2.6)9(3.3)*ǂ 
 
Standard Care 
Energy Expenditure 
(kcal/kg/day):  
No  9.7(4.5)9.6(4.3) 
 
Combined Treatment/Standard  
Care 
Energy Expenditure  
(kcal/kg/day): 
↑ 8.3(2.5)10.5(4.4)*ǂ 
 
Exercise Performance:  
6MWT (m) 
Treatment Alone 
↑ 97.2(85.4)119.3(95.7)* 
 
Standard Care 
↑ 157(100)181(116.2)* 
 
Combined Treatment/Standard  
Care 
↑ 89.5(73.4)109.5(71.4)* 
 
 
Witham et al. 
 
2005 
 
RCT 
 
Level 1b 
 
M&HR 90% 
Treatment 
N:41 
Age: 80(6) 
M/F: 26/15 
NYHC: 
II: 25 
III: 16 
LVSD: 
mild: 14 
moderate: 12 
severe: 15 
 
Control 
N = 41 
Age:81(4) 
M:F = 19:22 
NYHC: 
II: 21 
III: 20 
LVSD: 
mild: 15 
moderate: 13 
severe: 13 
Visits 
30 minutes, 2x/week for 
3 months, followed by  
2 - 3x/week at home for 
3 months 
 
Intensity 
Borg Scale 11 - 13 
 
Type 
Gentle seated exercise  
for first 3 months, then 
home exercise with  
assist of video/cassette 
for 3 months. Activity  
diary and weekly  
physiotherapist phone  
calls for encouragement 
and walking activity  
goal-setting were  
included 
 
Control Group  
Standard medical care 
Triaxial accelerometer  
Treatment  
92,565(51,227)106,021(98,315)
109,150(70,385)*ǂ 
 
Control Group  
No  95,163(62,190)  
93,373(62,862)82,463(53,832) 
 
 
Exercise Performance: 
6MWT (m)  
Treatment  
No  261(117)254(107)  
262(110) 
 
Control 
No  240(93)228(102)  
246(111) 
 
Functional Status: 
Functional Limitations Profile 
No  in either group 
 
 
Quality of Life: 
Chronic Heart Failure  
Questionnaire 
No  in either group 
 
Anxiety/Depression: 
Hospital Anxiety Depression  
 
Score  
No  in either group 
Mueller et al. 
 
2007 
 
Level 2b 
 
M&HR 70% 
Treatment 
N:25 
Age: NR 
M/F: 25/0 
LVEF(%): < 40 
NYHC: NR 
 
Control 
N:25 
Age: NR 
M/F: 25/0 
LVEF: <40 
NYHC: NR 
 
Visits 
30 minutes 5x/wk, with 
additional 45 minutes,  
2x/week for 1 month,  
6.2 year follow-up 
 
Intensity 
60% - 80% of max HR 
or Borg Scale 12 - 14 
 
Type 
30 minutes cycling, 
45 minutes walking 
 
Control Group: 
Standard medical care 
Questionnaire Modeled after  
Harvard Alumni Study  
(kcal/week) 
Treatment 
No  2137(2021)→2704(1970) 
 
Control  
No  1269(1162)→2085(1522) 
 
(Activity only recorded at 6.2 year 
follow-up) 
Exercise Performance: 
Peak VO2 (mL/kg/min) 
Treatment 
No  22.0(3.4)26.7(4.3)*→ 23.6(5.8)
*significant immediate post 
training difference only 
Control 
No  19.9(2.7)20.0(2.9)→  
20.3(4.5) 
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Witham et al. 
 
2012 
 
Level 1b 
MH&R 90% 
Treatment 
N:53 
Age: 80(6) 
M/F: 35/8 
NYHC: 
II: 37 
III: 16 
LVSD: 
mild: 28 
moderate: 13 
severe: 9 
 
Control 
N=54 
Age:80(5) 
M:F=37:14 
NYHC: 
II: 48 
III: 6 
LVSD: 
mild: 22 
moderate: 17 
severe: 14 
Visits 
60 minutes, 2x/week for 
8 weeks, followed by 16 
weeks of home exercise 
 
Intensity 
Based on dyspnea 
 
Type 
Gentle seated exercise  
for first 3 months, then  
home exercise with  
assist of video/cassette  
for 3 months.  
Group-based, guided  
discussions regarding  
exercise, support calls  
by physiotherapist every 
2 weeks for 8 weeks,  
then monthly support  
calls for 16 weeks.  
 
Control Group  
Standard medical care 
Triaxial accelerometer  
No difference in change between  
groups at 8 or 16 weeks 
 
Exercise Performance: 
6MWT (m)  
No difference in change between  
groups at 8 or 16 weeks 
 
Quadriceps Strength 
No difference in change between  
groups at 8 or 16 weeks 
 
Functional Status: 
Functional Limitations Profile 
No difference in change between  
groups at 8 or 16 weeks 
 
 
Quality of Life: 
Chronic Heart Failure  
Questionnaire 
No difference in change between  
groups at 8 or 16 weeks 
 
EuroQoL 
No difference in change between  
groups at 8 or 16 weeks 
 
 
Anxiety/Depression: 
Hospital Anxiety Depression  
Score  
No difference in change between  
groups at 8 or 16 weeks 
*Statistically significant within-group difference; ǂStatistically significant between-group difference compared to control; values represent mean (standard devia- 
tion); MH&R = Medlicott & Harris rating of methodological rigor; LVEF = left ventricular ejection fraction; NYHC = New York Heart Association Classifica- 
tion; NR = not reported; UE = upper extremity; LE = lower extremity; 6MWT = 6 Minute Walk Test; VO2 = peak oxygen consumption; CES-D = Center for 
Epidemiologic Studies Depression Questionnaire; LVSD = left ventricular systolic dysfunction. 
 
3.1.4. Follow-Up 
Only two studies [39,41] measured long-term results (6- 
month or greater follow-up). The majority [37,38,40, 
42,43] of studies had no follow-up after intervention 
concluded. 
3.1.5. Intervention Type and Dosage 
Five studies [38-43] used exercise interventions, one 
study [37] used psychosocial intervention, and two stud- 
ies [42,43] used an exercise intervention with a psycho- 
social component. The average length of intervention 
was 3.33 months, with a range of 1 month [39] to 6 
months [38,43]. Frequency of intervention ranged from 
two times per week [40] to seven times per week [39], 
with the other four studies at 2 - 3 times per week. 
3.1.6. Daily Activity Measures and Outcomes 
Several different daily activity measures were utilized. 
Four [38,40,42,43] of the seven studies used accelerome- 
try, while the other three [37,39,41] used either a ques- 
tionnaire or an activity diary. One study [38] used dou- 
bly-labeled water in conjunction with accelerometry. 
Only two studies [37,42] showed between-group im- 
provements in daily activity. The remaining five studies 
[38-41,43] demonstrated no improvements in daily ac- 
tivity. 
3.1.7. Exercise Performance Measures and Outcomes 
Measurements included the 6MWT [37,38,40,42,43], 
peak VO2 [38,40,41], heart rate [39], and various mus- 
cular performance tests. Two studies [38,40] demon- 
strated improvements across multiple measures of exer- 
cise performance. The most commonly used measures 
were peak VO2 [38,40,41] and the 6MWT [37,38,40, 
42,43]. Significant between-group changes in 6MWT 
[38], peak VO2 [38,40], exercise duration [38], and peak 
torque [40] were found in two of seven studies. 
3.1.8. Quality of Life Measures and Outcomes 
Five studies [38,40-43] measured quality of life (QOL). 
Measures included: Minnesota Living with Heart Failure 
Questionnaire [38], Medical Outcomes Study-SF 36 [38], 
Philadelphia Geriatric Morale Score [42], Chronic Heart 
Failure Questionnaire [42,43], Patient Global Assessment 
of Change in Quality of Life [41], and EuroQoL [43]. 
Significant between-group differences as a result of the 
intervention were only found in one study using the Pa- 
tient Global Assessment of Change in Quality of Life [41]. 
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3.1.9. Anxiety/Depression Measures and Outcomes 
Three studies [38,42,43] measured anxiety/depression 
outcomes. Depression/anxiety measures included the 
Center for Epidemiologic Studies Depression Question- 
naire [38] and the Hospital Anxiety and Depression Scale 
[42,43]. No changes in anxiety/depression were found. 
3.1.10. Functional Status Measures and Outcomes 
Three studies measured functional status [38,42,43]. 
Measures included the Function Status Assessment [38] 
and the modified Functional Limitations Profile [42,43]. 
No study reported significant between-group differences 
in any of the aforementioned measures. 
3.1.11. Concurrent Changes between Daily Activity 
and Secondary Outcomes 
Figure 2 summarizes the relationship between changes 
in daily activity concurrent with changes in other second- 
dary outcome measures by plotting the within-group ef- 
fect sizes of the intervention groups for all measures 
across all seven studies. Overall, a positive linear rela- 
tionship did not exist, with the greatest changes in daily 
activity not occurring concurrently with changes in other 
measures. Furthermore, only one study [37] demon- 
strated a within-group effect size greater than 0.50 for 
daily activity. 
When assessing concurrent changes in daily activity 
and anxiety/depression, there were no consistent results; 
two studies [38,43] showed no changes in daily activity 
or anxiety/depression, another study [42] demonstrated 
an increase in daily activity without a concurrent im- 
provement in anxiety/depression, while yet another study  
[40] showed improvement in anxiety/depression without 
an improvement in daily activity. No studies found con- 
current change in daily activity and anxiety/depression. 
In evaluating concurrent change in daily activity and 
QOL, three studies [38,40,43] showed no change in ei- 
ther daily activity or QOL. One study [41] showed in- 
creased daily activity but no improvement in QOL. An- 
other study [41] showed improvement in QOL but no 
increase in daily activity. No studies found concurrent 
change in daily activity and QOL. 
In the assessment of concurrent change in daily activ- 
ity and functional status, three studies [38,41,43] found 
no change in daily activity or functional status. Two 
studies [37,42] found increased daily activity without an 
increase in activity participation. No study showed an 
increase in daily activity and activity participation con- 
currently.  
In comparing concurrent changes among daily activity 
and exercise performance, three studies [39,41,43] 
showed no change in daily activity or exercise perform- 
ance. Two studies [37,42] showed increases in daily ac- 
tivity without associated changes in exercise perform- 
ance. Two studies [38,39] demonstrated improvements in 
exercise performance but no increase in daily activity. 
No studies found concurrent change in daily activity and 
exercise performance. 
3.2. COPD 
One hundred and eighty four unique articles were found 
using the search strategy previously outlined. Ultimately, 
nine studies [44-52] met the inclusion criteria for this 
review: three randomized control trials [45,47,48], one 
 
 
Figure 2. Concurrent intervention within-group effect sizes for daily activity and other 
outcome measures in CHF studies. 
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cohort study [44], and five case control studies [44, 
46,49,51,52] (Figure 3). Methodological rigor scores 
ranged from 40% [51] to 90% [45]. One study [44] was 
rated as “strong”, seven studies [44,46-50,52] were 
judged to be “moderate”, and one study [50] was de- 
termined to be “weak”. Of these nine studies, two [47,49] 
were unique to this search from the previous systematic 
review and meta-analysis by Ng et al. [30]. As discussed 
previously, Ng et al. [30] concluded that exercise train- 
ing had little-to-no effect on physical activity in patients 
with COPD. For further details regarding the results and 
details of these seven included studies, refer to the full 
text article by Ng et al. [30]. 
The two additional articles found by the present lit- 
erature search reported similar conclusions. Slinde et al. 
[49] explored how total daily energy expenditure 
changes when underweight patients with COPD enter a 
physiotherapy program. Fourteen subjects meeting the 
inclusion criteria of severe COPD, as indicated by FEV1 
less than 50%, and body mass-index of less than twenty- 
one kg/m2, completed the study. In total, subjects at- 
tended eight, 90-minute physical therapy sessions con- 
sisting of moderate physical activity and an educational 
intervention. The authors concluded, based on acceler- 
ometer and doubly-labeled water measurements, that the 
mean total energy expenditure actually decreased 6% 
during the intervention period as compared to the control, 
with between-group results not statistically significant. 
Probst et al. [47] compared the effect of a high inten- 
sity, whole-body endurance and strength program to a 
low-intensity calisthenics-and-breathing exercise pro- 
gram to improve daily activity. Forty individuals with 
 
 
Figure 3. Search results for chronic obstructive pulmonary 
disease. 
COPD were randomized into two equal treatments groups 
and completed 36 therapy sessions over a 12 week period. 
Based on accelerometry, Probst et al. [47] concluded that 
neither high- nor low-intensity treatment had a signifi- 
cant impact on improving daily energy expenditure. 
Concurrent Changes between Daily Activity and 
Secondary Outcomes 
Figure 4 summarizes the relationship between changes 
in daily activity concurrent with changes in other second- 
dary outcome measures by plotting the within-group effect 
sizes of the intervention groups for all measures across 
all nine studies. Overall, a positive linear relationship did 
not exist, with the greatest changes in daily activity not 
occurring concurrently with changes in other measures. 
Furthermore, only one study [45] demonstrated a within- 
group effect size greater than 0.50 for daily activity, with 
small-to-no effects in all other outcome measures when 
daily activity effect sizes where greater than 0.50. 
When assessing concurrent changes in daily activity 
and anxiety/depression, one study [50] showed no changes 
in daily activity or anxiety/depression and another de- 
monstrated a large effect on daily activity but no effect 
on anxiety/depression [45]. Only one study [52] showed 
concurrent increase in daily activity and improved anxi- 
ety/depression. 
With regard to concurrent changes in daily activity 
and QOL, four studies [45,47,48,50] showed no change 
in either daily activity or QOL. One study [44] showed 
improved QOL with no increase in daily activity. Two 
studies [46,52] demonstrated concurrent change in in- 
creased daily activity and improved QOL. 
In the assessment of concurrent change in daily activ- 
ity and functional status, four studies [45,47,48,50] found 
no change in daily activity and participation. One study 
[44] showed increased functional status with no positive 
effect on daily activity. Two studies [46,52] showed con- 
current change in increased daily activity and improved 
functional status. 
In comparing concurrent changes among daily activity 
and exercise performance, two studies [45,48] showed no 
change in daily activity or exercise performance. One 
study [52] showed increased daily activity without asso- 
ciated improvement in exercise performance. Three stu- 
dies [44,47,50] demonstrated improvements in exercise 
performance but no increase in daily activity. Only one 
study [46] found a concurrent increase in daily activity 
and improved exercise performance. 
4. DISCUSSION 
The purpose of the present review was to evaluate the 
efficacy of exercise- and psychosocial-based intervene- 
ions for improving daily activity in patients with COPD  t  
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Figure 4. Concurrent intervention within-group effect sizes for daily activity 
and other outcome measures in COPD studies. 
 
and CHF. The results of the present review highlight 
several important limitations of the existing literature. 
More importantly, however, the present review provides 
insight into interventions utilized for disrupting the cycle 
of inactivity and deconditioning in individuals with 
COPD and CHF. Overall, the present results indicate that 
exercise-based interventions play a limited role in im- 
proving daily activity, and psychosocial-based interven- 
tions are a promising, but under-investigated, interven- 
tion. 
With regard to limitations of the existing literature on 
interventions for improving daily activity in individuals 
with COPD and CHF, there are several noteworthy study 
design and measurement deficiencies. Although there 
were a greater number of studies of patients with COPD, 
few utilized a randomized design compared to all six of 
the studies in patients with CHF being randomized con- 
trolled trials. However, the measurement of daily activity 
in the CHF literature included an objective measurement 
(e.g. accelerometry) in only four studies, compared to 
objective measures being used in all nine in the COPD 
literature. It is therefore helpful to draw upon evidence 
from both populations when evaluating intervention ef- 
ficacy. Indeed, similar findings were noted in both, with 
exercise-based interventions having little effect on daily 
activity. 
With regard to the role of either exercise- and/or psy- 
chosocial-based interventions for disrupting the cycle of 
inactivity and deconditioning, psychosocial interventions 
appeared to have the greatest efficacy. Only four of nine 
studies [45,46,48,52] in patients with COPD showed 
within-group improvement in daily activity, and none 
demonstrated between-group changes. Similarly, two of 
seven studies [37,42] in patients with CHF resulted in 
statistically significant effects on daily activity. However, 
among the studies that demonstrated a statistically sig- 
nificant effect on daily activity, three of the four studies 
in those with COPD [45,46,48] and both of the studies in 
those with CHF [37,42] included a psychosocial compo- 
nent or were entirely a psychosocial-based intervention. 
With regard to the cycle of inactivity and decondi- 
tioning, the results of the present study could be inter- 
preted in two ways: 1) inactivity and deconditioning are 
not interrelated as previously proposed [8-12], or, 2) only 
directing interventions towards the deconditioning com- 
ponent of the cycle is insufficient for making changes in 
daily activity. In patients with CHF, Shoemaker et al. [53] 
observed that clinically meaningful changes in 6MWT 
performance were not accompanied by changes in daily 
activity over time (no intervention was provided). Fur- 
thermore, as noted in the present review, changes in ex- 
ercise performance in response to exercise interventions 
did not occur concurrently with changes in daily activity 
(e.g. studies that demonstrated improved exercise per- 
formance did not improve in daily activity and vice 
versa). As previously discussed, nearly all of the studies 
in both populations that included at least a psychosocial 
intervention component resulted in improvements in 
daily activity. 
Therefore, psychosocial-based interventions for im- 
proving daily activity, although relatively under-investi- 
gated in COPD and CHF, may be a promising new inter- 
vention. It is not clear whether psychosocial-based inter- 
ventions alone or in combination with exercise-based 
interventions are most effective. Furthermore, it is not 
known which psychosocial interventions are effective, as 
Copyright © 2013 SciRes.                                                                       OPEN ACCESS 
M. J. Shoemaker et al. / World Journal of Cardiovascular Diseases 3 (2013) 275-286 284 
highlighted by the 2005 and 2012 studies by Witham et 
al. The very low intensity, seated exercise intervention in 
the 2005 study that resulted in significant improvement 
in daily activity included subjects keeping “a diary of 
their daily activities [that was] used as a basis for a 
weekly telephone liaison [to] give encouragement and 
agree on new targets for daily walking activity.” The 
high intensity exercise intervention in the 2012 study that 
failed to demonstrate improvement in daily activity in- 
cluded “guided discussion sessions based on cognitive 
and behavioral techniques [that focused] on benefits of 
exercise [and] goals and how to work toward them” in 
addition to telephone calls every 2 weeks for the first 4 
months followed by monthly phone calls for 4 months. 
Thus, the key components of psychosocial support or 
intervention for promoting changes in the habitual rou- 
tines that impact daily activity are not clear. 
Finally, the present review found that changes in QOL, 
anxiety/depression, and functional status did not occur 
concurrently with changes in daily activity. Although 
daily activity has been shown to be associated with anxi- 
ety/depression, QOL, and functional status [18,19,24,26- 
28,54], it is not clear why changes in these measures did 
not consistently occur concurrently. No included study 
investigated the effect of pharmacologic or functional 
training interventions directed at improving anxiety/de- 
pression or functional status or how such interventions 
might impact daily activity. It is important to note that 
none of the included studies specifically accounted for 
baseline depression, anxiety, or low selfefficacy as pos- 
sible factors that could confound response to interven- 
tion. 
In summary, based on the results of the present sys- 
tematic review, it can be concluded that exercise-based 
interventions alone are unable to promote an increase in 
daily activity within the COPD and CHF populations. 
Given the association between daily activity and other 
important outcomes such as hospitalization and mortality, 
clinicians should consider daily activity as clinical out- 
come, and should also consider the psychosocial needs of 
patients as they pertain to daily activity. 
Future research should focus on expanding the appli- 
cation of psychosocial-based interventions in subjects 
with COPD and CHF. While current evidence of psy- 
chosocial-based intervention is promising, the volume of 
studies is limited. Future research should also compare 
the efficacy of exercise-based intervention versus psy- 
chosocial-based interventions versus a combination of 
exercise and psychosocial intervention to improve daily 
activity in individuals with COPD and CHF. 
5. CONCLUSION 
Exercise-based interventions serve a limited, if any, role 
in improving daily activity in individuals with COPD 
and CHF. Disrupting the cycle of inactivity and decondi- 
tioning requires more than just addressing the decondi- 
tioning aspect of this cycle. Psychosocial-based inter- 
ventions are a promising, but under-investigated, inter- 
vention. 
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